Skip to content

KIORA PHARMACEUTICALS INC

KPHMW KPRX

CIK 0001372514 · Pharmaceutical Preparations · Nasdaq, OTC

  • EYEGATE PHARMACEUTICALS INC (until 2021-11-04)
← back to feed
Revenue (TTM)
$0
−100.0% YoY Q1 May 2026
Net Income (TTM)
−$6.74M
−401.4% YoY Q1 May 2026
EPS Diluted (TTM)
−$1.63
−403.4% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
$4.58M
Q1 May 2026
Cash
$10.96M
Q1 May 2026
Total Debt
$278.19K
Q1 May 2026
Shares Outstanding
4.43M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings